Bumper Offer - Urjas oil Just @ Rs. 1 X
Zathrin DT 100 Tablet (3) is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Ear Infection, Tonsillitis, Pneumonia. The alternative uses of Zathrin DT 100 Tablet (3) have also been explained below.
The optimal dosage of Zathrin DT 100 Tablet (3) is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Zathrin DT 100 Tablet (3) include Nausea or vomiting, Diarrhoea, Headache. Some other side effects of Zathrin DT 100 Tablet (3) have been listed ahead. Usually, these side effects of Zathrin DT 100 Tablet (3) go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Zathrin DT 100 Tablet (3)'s effect during pregnancy is Safe and Safe while nursing. It is important to know if Zathrin DT 100 Tablet (3) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Zathrin DT 100 Tablet (3) related warnings section.
The section on Zathrin DT 100 Tablet (3) contraindications lists all such conditions.
Drug reaction of Zathrin DT 100 Tablet (3) with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Zathrin DT 100 Tablet (3) is safe while driving, and is is addictive in nature.
Zathrin DT 100 Tablet (3) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult(Female) |
|
| Adult(Male) |
|
Based on research, the following side effects have been observed when Zathrin DT 100 Tablet (3) is used -
Severe
Moderate
Mild
Common
Is the use of Zathrin DT 100 Tablet (3) safe for pregnant women?
There are no side effects of Zathrin in pregnant women.
Is the use of Zathrin DT 100 Tablet (3) safe during breastfeeding?
Breastfeeding women can safely use Zathrin.
What is the effect of Zathrin DT 100 Tablet (3) on the Kidneys?
Zathrin rarely harms the kidneys.
What is the effect of Zathrin DT 100 Tablet (3) on the Liver?
Side effects of Zathrin rarely affect the liver.
What is the effect of Zathrin DT 100 Tablet (3) on the Heart?
Very few cases of side effects of Zathrin on the heart have been reported.
Zathrin DT 100 Tablet (3) should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Zathrin DT 100 Tablet (3) unless your doctor advises you to do so -
Is this Zathrin DT 100 Tablet (3) habit forming or addictive?
Forming a habit of Zathrin DT 100 Tablet (3) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Zathrin DT 100 Tablet (3) as it does not make you drowsy.
Is it safe?
Zathrin DT 100 Tablet (3) should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Zathrin DT 100 Tablet (3) for mental disorders.
Interaction between Food and Zathrin DT 100 Tablet (3)
Taking Zathrin DT 100 Tablet (3) with food does not harm your health.
Interaction between Alcohol and Zathrin DT 100 Tablet (3)
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Zathrin DT 100 Tablet (3).
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zithromax (azithromycin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 754
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zithromax (azithromycin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 754
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zithromax (azithromycin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 754
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zithromax (azithromycin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 754
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zithromax (azithromycin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 754
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zithromax (azithromycin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 754
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zithromax (azithromycin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 754
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zithromax (azithromycin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 754
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zithromax (azithromycin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 754